Denali Therapeutics Inc. (DNLI)

NASDAQ: DNLI · Real-Time Price · USD

21.43

+0.12 (0.56%)

At close: Mar 10, 2026, 4:00 PM EDT

21.25

-0.18 (-0.84%)

After-hours: Mar 10, 2026, 7:43 PM EDT

Denali Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	205.33	174.96	127.11	218.04	293.48
Short-Term Investments	662.55	657.37	907.41	1,118	571.93
Cash & Short-Term Investments	867.88	832.33	1,035	1,336	865.41
Cash Growth	4.27%	-19.54%	-22.58%	54.40%	-41.12%
Other Receivables	-	-	-	-	1.23
Total Trade Receivables	-	-	-	-	1.23
Other Current Assets	32.78	32.11	29.63	36.1	30.6
Total Current Assets	900.66	864.44	1,064	1,372	897.23
Net Property, Plant & Equipment	119.94	125.63	71.64	74.52	69.61
Long-Term Investments	98.32	359.37	-	-	425.45
Other Long-Term Assets	25.94	24.74	18.14	13.4	11.87
Total Assets	1,145	1,374	1,154	1,460	1,404
Accounts Payable	3.33	11.14	9.48	2.79	4.78
Accrued Expenses	95.02	91.07	68.5	66.69	53.17
Unearned Revenue	-	-	-	290.05	320.3
Other Current Liabilities	-	-	-	4.39	-
Total Current Liabilities	98.35	102.21	77.98	363.92	378.25
Long-Term Leases	32.74	42.29	44.98	53.03	58.55
Other Long-Term Liabilities	-	-	-	0.86	5.07
Total Long-Term Liabilities	32.74	42.29	44.98	53.89	63.63
Total Liabilities	131.09	144.5	122.96	417.81	441.87
Common Stock	1.89	1.77	1.71	1.69	1.55
Additional Paid-in Capital	3,063	2,765	2,145	2,019	1,608
Accumulated Other Comprehensive Income	0.68	2.02	0.64	-6.89	-2.5
Retained Earnings	-2,052	-1,539	-1,116	-970.99	-645
Shareholders' Equity	1,014	1,230	1,031	1,042	962.29
Total Liabilities & Equity	1,145	1,374	1,154	1,460	1,404
Total Debt	32.74	42.29	44.98	53.03	58.55
Net Cash (Debt)	835.14	790.04	989.53	1,283	806.85
Net Cash Growth	5.71%	-20.16%	-22.88%	59.04%	-42.59%
Net Cash Per Share	4.84	4.80	7.20	10.22	6.64
Book Value	1,014	1,230	1,031	1,042	962.29
Book Value Per Share	5.87	7.48	7.50	8.30	7.92
Tangible Book Value	1,014	1,230	1,031	1,042	962.29
Tangible Book Value Per Share	5.87	7.48	7.50	8.30	7.92

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q